Engraftment and outcomes of patients receiving myeloablative therapy followed by autologous peripheral blood stem cells with a low CD34+ cell content.

Source:http://linkedlifedata.com/resource/pubmed/id/9193753

Download in:

View as

General Info

PMID
9193753